Sign In

Remember Me

telomeres

Review: Rejuvenation Biotech Conference

Review: Rejuvenation Biotech Conference

Fifteen years ago, Aubrey de Grey organized the first SENS roundtable–Strategies for Engineering Negligible Senescence. It was a small group of out-of-the-box thinkers, heretics who talked about attacking head-on the idea that aging is just part of the human condition, looking for medical (and beyond-medical) treatments that would restore strength, stamina, and alertness, and lower the risk of al...

Read More »
Anti-Aging Science: Despite Progress, Challenges Remain

Anti-Aging Science: Despite Progress, Challenges Remain

Last month a team of doctors and scientists made the case to regulators at the Food and Drug Administration (FDA) to consider approving anti-aging drugs as a new pharmaceutical class. Such a designation would treat aging as disease rather than a natural process, potentially opening the door to government funding for anti-aging drug trials. To some, such a drug may seem impossible. Yet, the physiol...

Read More »